OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody-drug conjugates: the clinical development in gastric cancer
Yingze Zhu, Miao Zhou, Wenyue Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Yingze Zhu, Miao Zhou, Wenyue Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Showing 12 citing articles:
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre A. Jácome, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 679-679
Open Access | Times Cited: 9
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre A. Jácome, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 679-679
Open Access | Times Cited: 9
Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit
Antonella Cammarota, Joshi Kroopa, Alinoor Mohamed Farah, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Antonella Cammarota, Joshi Kroopa, Alinoor Mohamed Farah, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5180-5180
Open Access | Times Cited: 6
Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5180-5180
Open Access | Times Cited: 6
Immunotherapy guided precision medicine in solid tumors
Sanjana Mehrotra, Manu Kupani, Jaismeen Kaur, et al.
Advances in protein chemistry and structural biology (2024), pp. 249-292
Closed Access | Times Cited: 1
Sanjana Mehrotra, Manu Kupani, Jaismeen Kaur, et al.
Advances in protein chemistry and structural biology (2024), pp. 249-292
Closed Access | Times Cited: 1
State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care
Nicole Baranda Balmaceda, Angelica Petrillo, Mridula Krishnan, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 1
Nicole Baranda Balmaceda, Angelica Petrillo, Mridula Krishnan, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 1
The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer
Hampig Raphaël Kourié, Mervat Mahrous, Nabih Naim, et al.
Future Oncology (2023) Vol. 19, Iss. 21, pp. 1451-1459
Closed Access | Times Cited: 3
Hampig Raphaël Kourié, Mervat Mahrous, Nabih Naim, et al.
Future Oncology (2023) Vol. 19, Iss. 21, pp. 1451-1459
Closed Access | Times Cited: 3
Feature Engineering-Assisted Drug Repurposing on Disease–Drug Transcriptome Profiles in Gastric Cancer
Kevser Kübra Kırboğa, Mithun Rudrapal
Assay and Drug Development Technologies (2024) Vol. 22, Iss. 4, pp. 181-191
Closed Access
Kevser Kübra Kırboğa, Mithun Rudrapal
Assay and Drug Development Technologies (2024) Vol. 22, Iss. 4, pp. 181-191
Closed Access
Progress and current perspectives of diagnosis and treatment of hepatoid adenocarcinoma of the stomach
Kai Qin, Jing Zhang, Gong Chen, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 2, pp. 54-59
Open Access
Kai Qin, Jing Zhang, Gong Chen, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 2, pp. 54-59
Open Access
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies
Jia-Lin Hao, Xinyun Li, Yu‐Tong Liu, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 887-906
Closed Access
Jia-Lin Hao, Xinyun Li, Yu‐Tong Liu, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 887-906
Closed Access
Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art
Jane E. Rogers, Qiong Gan, Rebecca Waters, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access
Jane E. Rogers, Qiong Gan, Rebecca Waters, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access
Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma
Margaret C. Wheless, M.B. Comer, Michael K. Gibson
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1469-1488
Open Access
Margaret C. Wheless, M.B. Comer, Michael K. Gibson
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1469-1488
Open Access
